Author(s)Glasner, Peter, ed.
Concept of Health
Social Control of Science and Technology
Genetics, Molecular Biology and Microbiology
Genetic Screening / Genetic Testing
Neurosciences and Mental Health Therapies
Information Science Ethics
Economics of Health Care
Health Care for Particular Diseases or Groups
Full recordShow full item record
AbstractList of tables and figures -- List of contributors -- Acknowledgements -- Ch. 1. Introduction: what's new about the `new genetics'? / Peter Glasner and Harry Rothman -- Pt. I. Literacy, public understanding and the media -- Ch. 2. The gene shop at Manchester airport / Mairi Levitt -- Ch. 3. Public understanding of genetic engineering in Germany / Jurgen Hampel -- Ch. 4. Predictive medicine, genetics and schizophrenia / John Turney and Jill Turner -- Pt. II. Commercialisation and health -- Ch. 5. Pharmacogenetics: implications for drug development, patients and society / Alun McCarthy -- Ch. 6. The use of large biological sample collections in genetics research: issues for public policy / Paul Martin and Jane Kaye -- Pt. III. Gen-ethics: human genetic banking -- Ch. 7. DNA sampling and banking in clinical genetics and genetic research / Kare Berg -- Ch. 8. Human genetic banking and the limits of informed consent / Garrath Williams and Doris Schroeder -- Ch. 9. Regulation and social perceptions of genetic data banking in Germany / Juergen Simon and Susanne Braun -- Pt. IV. Genetic screening -- Ch. 10. Genetic and nongenetic medical information: is there a moral difference in the context of insurance? / Veikko Launis -- Ch. 11. New practices of screening in the field of cancergenetics: a co-evolutionary perspective / Dirk Stemerding and Annemiek Nelis -- Ch. 12. Lumping and splitting revisited: or what happens when the new genetics meets disease classification /Adam M. Hedgecoe -- Pt. V. Cloning and xenotransplantation -- Ch. 13. What we know and what we don't about cloning and society / Sarah Franklin -- Ch. 14. Containing contradictions: debating nature, controversy and biotechnology / Nik Brown -- Ch. 15. Constructing the scientific citizen: science and democracy in the biosciences / Alan Irwin -- Ch. 16. Conclusion / Peter Glasner -- Index
Aldershot, Hampshire/Burlington, VT: Ashgate, 2004. 330 p.
Showing items related by title, author, creator and subject.
Al-muwakabah al-Shar'iyah li mu'tayat al-handasah al-wirathíyahAbu Ghuddah, 'Abd al-Sattar (2016-01-08)This paper was submitted to the symposium held by the Islamic Organization for Medical Sciences (IOMS) in Kuwait during the period 13-15 October 1998 on genetics. The paper presents detailed juristic answers for different questions raised by the applications of genetic engineering such as prenatal diagnostic testing especially in case of endogamous marriage, gene therapy, genetic privacy and selective abortion.
Al-Wirathah Wa Al-Handasah Al-Wirathiyah Wa Al-Jinum Al-Bashari Wa Al-'Ilaj Al-Jini: Ru'yah Islamiyah (Al-Juz' Al-Awwal) Al-Wirathah Wa Al-Handasah Al-Wirathiyah Wa Al-Jinum Al-Bashari Genetics, Genetic Engineering, Human Genome and Genetic Therapy: An Islamic Perspective (Vol. 1) Genetics, Genetic Engineering and the Human GenomeJundi, Ahmad Raja'i (2016-01-08)
Privacy-preserving genomic testing in the clinic: A model using HIV treatmentMclaren P.J.; Raisaro J.L.; Aouri M.; Rotger M.; Ayday E.; Bartha I.; Delgado M.B.; Vallet Y.; Günthard H.F.; Cavassini M.; et al. (Nature Publishing Group, 2018-04-12)Purpose:The implementation of genomic-based medicine is hindered by unresolved questions regarding data privacy and delivery of interpreted results to health-care practitioners. We used DNA-based prediction of HIV-related outcomes as a model to explore critical issues in clinical genomics.Methods:We genotyped 4,149 markers in HIV-positive individuals. Variants allowed for prediction of 17 traits relevant to HIV medical care, inference of patient ancestry, and imputation of human leukocyte antigen (HLA) types. Genetic data were processed under a privacy-preserving framework using homomorphic encryption, and clinical reports describing potentially actionable results were delivered to health-care providers.Results:A total of 230 patients were included in the study. We demonstrated the feasibility of encrypting a large number of genetic markers, inferring patient ancestry, computing monogenic and polygenic trait risks, and reporting results under privacy-preserving conditions. The average execution time of a multimarker test on encrypted data was 865 ms on a standard computer. The proportion of tests returning potentially actionable genetic results ranged from 0 to 54%.Conclusions:The model of implementation presented herein informs on strategies to deliver genomic test results for clinical care. Data encryption to ensure privacy helps to build patient trust, a key requirement on the road to genomic-based medicine. © 2015 American College of Medical Genetics and Genomics.